Pulmonary Fibrosis Caused by Severe COVID-19 Infection: Discharge May Not Be The End of Treatment

被引:0
|
作者
Rumende, Cleopas Martin [1 ]
机构
[1] Univ Indonesia, Cipto Mangunkusumo Hosp, Fac Med, Dept Internal Med, Jakarta, Indonesia
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:141 / 142
页数:2
相关论文
共 50 条
  • [1] Discharge may not be the end of treatment: Pay attention to pulmonary fibrosis caused by severe COVID-19
    Zhang, Chi
    Wu, Zhao
    Li, Jia-Wen
    Tan, Kangan
    Yang, Wanna
    Zhao, Hong
    Wang, Gui-Qiang
    JOURNAL OF MEDICAL VIROLOGY, 2021, 93 (03) : 1378 - 1386
  • [2] CASE REPORT OF SEVERE PULMONARY FIBROSIS AS A SEQUELAE OF COVID-19 INFECTION
    Arjun, Shiva
    Patel, Dolly
    Sanivarapu, Raghavendra
    Iqbal, Javed
    Anjum, Fatima
    CHEST, 2020, 158 (04) : 433A - 434A
  • [3] Molecular mechanisms and treatment responses of pulmonary fibrosis in severe COVID-19
    Emma J. Kooistra
    Kilian Dahm
    Antonius E. van Herwaarden
    Jelle Gerretsen
    Melanie Nuesch Germano
    Karoline Mauer
    Ruben L. Smeets
    Sjef van der Velde
    Maarten J. W. van den Berg
    Johannes G. van der Hoeven
    Anna C. Aschenbrenner
    Joachim L. Schultze
    Thomas Ulas
    Matthijs Kox
    Peter Pickkers
    Respiratory Research, 24
  • [4] Molecular mechanisms and treatment responses of pulmonary fibrosis in severe COVID-19
    Kooistra, Emma J. J.
    Dahm, Kilian
    van Herwaarden, Antonius E. E.
    Gerretsen, Jelle
    Germano, Melanie Nuesch
    Mauer, Karoline
    Smeets, Ruben L. L.
    van der Velde, Sjef
    van den Berg, Maarten J. W.
    van der Hoeven, Johannes G. G.
    Aschenbrenner, Anna C. C.
    Schultze, Joachim L. L.
    Ulas, Thomas
    Kox, Matthijs
    Pickkers, Peter
    RESPIRATORY RESEARCH, 2023, 24 (01)
  • [5] First Successful Lung Transplantation for Pulmonary Fibrosis Due to Severe COVID-19 Infection in the US
    Kurihara, C.
    Bharat, A.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2021, 40 (04) : S499 - S500
  • [6] Treatment Ventilators may not be best for severe covid-19
    Wilson, Clare
    NEW SCIENTIST, 2020, 245 (3285) : 11 - 11
  • [7] The potential indicators for pulmonary fibrosis in survivors of severe COVID-19
    Huang, Wenhui
    Wu, Qingxia
    Chen, Zhuozhi
    Xiong, Zhiyuan
    Wang, Kun
    Tian, Jie
    Zhang, Shuixing
    JOURNAL OF INFECTION, 2021, 82 (02) : E5 - E7
  • [8] Pulmonary fibrosis and COVID-19
    Kramer, Daniel
    Hilton, Robert
    Roman, Jesse
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2023, 366 (04) : 245 - 253
  • [9] Complications after discharge with COVID-19 infection and risk factors associated with development of post-COVID pulmonary fibrosis
    Aul, Raminder
    Gates, Jessica
    Draper, Adrian
    Dunleavy, Anne
    Ruickbie, Sachelle
    Meredith, Helen
    Walters, Nicola
    van Zeller, Cristiano
    Taylor, Victoria
    Bridgett, Michael
    Dunwoody, Roisin
    Grubnic, Sisa
    Jacob, Tersesa
    Ong, Yee Ean
    RESPIRATORY MEDICINE, 2021, 188
  • [10] Clozapine treatment and risk of severe COVID-19 infection
    Ohlis, Anna
    Wallin, Alma Sorberg
    Sarafis, Anna
    Sjoqvist, Hugo
    MacCabe, James H.
    Ahlen, Johan
    Dalman, Christina
    ACTA PSYCHIATRICA SCANDINAVICA, 2022, 145 (01) : 79 - 85